Detalles de la búsqueda
1.
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.
Blood
; 119(20): 4719-22, 2012 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22442349
2.
Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
Blood
; 116(15): 2742-51, 2010 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20581309
3.
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).
Blood
; 115(18): 3776-86, 2010 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20203266
Resultados
1 -
3
de 3
1
Próxima >
>>